AptarGroup, Inc. (ATR)

Market Cap	9.73B
Revenue (ttm)	3.58B
Net Income (ttm)	374.54M
Shares Out	66.50M
EPS (ttm)	5.53
PE Ratio	26.46
Forward PE	26.35
Dividend	$1.80 (1.23%)
Ex-Dividend Date	Feb 5, 2025

Volume	451,851
Open	147.03
Previous Close	146.68
Day's Range	145.22 - 147.39
52-Week Range	135.96 - 178.03
Beta	0.59
Analysts	Strong Buy
Price Target	183.75 (+25.56%)
Earnings Date	Feb 6, 2025

About ATR

AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; an...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Apr 21, 1993
• Employees: 13,500
• Stock Exchange: NYSE
• Ticker Symbol: ATR
• Website: https://www.aptar.com

Financial Performance

In 2024, AptarGroup's revenue was $3.58 billion, an increase of 2.74% compared to the previous year's $3.49 billion. Earnings were $374.54 million, an increase of 31.65%.

Analyst Forecast

According to 5 analysts, the average rating for ATR stock is "Strong Buy." The 12-month stock price forecast is $183.75, which is an increase of 25.56% from the latest price.

Price Target

$183.75

(25.56% upside)

Analyst Consensus: Strong Buy